Global Targeted Sequencing And Resequencing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Targeted Sequencing And Resequencing Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

Targeted sequencing and resequencing are two types of DNA sequencing techniques used to study specific regions of the genome. Targeted sequencing involves selectively sequencing specific regions of interest within the genome. This is achieved by using probes or primers that are designed to bind to and amplify only the desired regions of DNA. Targeted sequencing is useful for studying specific genes or regions of interest, such as those associated with a particular disease. Resequencing, on the other hand, involves sequencing an entire genome or a specific region of the genome to identify genetic variations or mutations. This technique is useful for comparing the DNA sequences of different individuals or populations to identify differences that may be associated with disease or other traits.

Market Dynamics

Precision medicine involves using genetic information to develop personalized treatment plans for patients. Targeted sequencing and resequencing technologies are critical for identifying genetic mutations that can cause or contribute to disease and for developing personalized treatment plans. The prevalence of genetic diseases such as cancer, rare genetic disorders, and cardiovascular diseases is increasing globally. Targeted sequencing and resequencing technologies are important tools for identifying genetic mutations that may cause these diseases, as well as for developing targeted therapies. Advances in sequencing technologies have made targeted sequencing and resequencing faster, more accurate, and more affordable. This has led to wider adoption of these technologies in research and clinical settings. Heavy investment in genomics research by various governments and to understand the genetic basis of diseases and develop new treatments. This is driving the demand for targeted sequencing and resequencing technologies. There is a growing awareness among individuals about the benefits of genetic testing for disease risk assessment, ancestry analysis, and personalized medicine. This is driving the demand for targeted sequencing and resequencing services in the consumer genomics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of targeted sequencing and resequencing. The growth and trends of targeted sequencing and resequencing industry provide a holistic approach to this study.

Market Segmentation

This section of the targeted sequencing and resequencing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Sequencing
Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing)

By Application

Clinical Application
Plant And Animal Sciences
Drug Development
Others

By Type

DNA-Based Targeted Sequencing
RNA-Based Targeted Sequencing

By End-Use

Hospitals & Clinics
Academic Research
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Targeted Sequencing And Resequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the targeted sequencing and resequencing market include Agilent Technologies, Illumina Inc., F. Hoffmann-La Roche Ltd, GATC Biotech Ag, DNASTAR Inc., QIAGEN, BGI, Oxford Nanopore Technologies, Thermo Fisher Scientific Inc., Perkin Elmer Inc., PacBio, RainDance Technologies Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., PierianDx, Genomatix GmbH, Macrogen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112110809

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . TARGETED SEQUENCING AND RESEQUENCING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By End-Use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY TECHNOLOGY

5.1 Overview by Technology
5.2 Historical and Forecast Data
5.3 Analysis by Technology
5.4 Sequencing Historic and Forecast Sales by Regions
5.5 Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Historic and Forecast Sales by Regions

6 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Clinical Application Historic and Forecast Sales by Regions
6.5 Plant And Animal Sciences Historic and Forecast Sales by Regions
6.6 Drug Development Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY TYPE

7.1 Overview by Type
7.2 Historical and Forecast Data
7.3 Analysis by Type
7.4 DNA-Based Targeted Sequencing Historic and Forecast Sales by Regions
7.5 RNA-Based Targeted Sequencing Historic and Forecast Sales by Regions

8 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY END-USE

8.1 Overview by End-Use
8.2 Historical and Forecast Data
8.3 Analysis by End-Use
8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
8.5 Academic Research Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE TARGETED SEQUENCING AND RESEQUENCING COMPANIES

10.1. Targeted Sequencing And Resequencing Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF TARGETED SEQUENCING AND RESEQUENCING INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Agilent Technologies
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Illumina Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. F. Hoffmann-La Roche Ltd
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. GATC Biotech Ag
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. DNASTAR Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. QIAGEN
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. BGI
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Oxford Nanopore Technologies
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Thermo Fisher Scientific Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Perkin Elmer Inc.
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. PacBio
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. RainDance Technologies Inc.
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Bio-Rad Laboratories Inc.
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. Integrated DNA Technologies Inc.
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments
11.17. PierianDx
- 11.17.1. Company Overview
- 11.17.2. Company Revenue
- 11.17.3. Products
- 11.17.4. Recent Developments
11.18. Genomatix GmbH
- 11.18.1. Company Overview
- 11.18.2. Company Revenue
- 11.18.3. Products
- 11.18.4. Recent Developments
11.19. Macrogen Inc.
- 11.19.1. Company Overview
- 11.19.2. Company Revenue
- 11.19.3. Products
- 11.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies